Skip to main content
Journal cover image

Molecular signatures that predict response to anthracycline-taxane based neoadjuvant chemotherapy

Publication ,  Conference
Blackwell, KL; Dressman, H; Olson, J; Rosen, E; Marcom, PK; Liotcheva, V; Jones, E; Vujaskovic, Z; Huper, G; Marks, J; Dewhirst, M; West, M; Nevins, J
Published in: BREAST CANCER RESEARCH AND TREATMENT
January 1, 2004

Duke Scholars

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

January 1, 2004

Volume

88

Start / End Page

S22 / S22

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

27th Annual Charles A Colman San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blackwell, K. L., Dressman, H., Olson, J., Rosen, E., Marcom, P. K., Liotcheva, V., … Nevins, J. (2004). Molecular signatures that predict response to anthracycline-taxane based neoadjuvant chemotherapy. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 88, pp. S22–S22). San Antonio, TX: SPRINGER.
Blackwell, K. L., H. Dressman, J. Olson, E. Rosen, P. K. Marcom, V. Liotcheva, E. Jones, et al. “Molecular signatures that predict response to anthracycline-taxane based neoadjuvant chemotherapy.” In BREAST CANCER RESEARCH AND TREATMENT, 88:S22–S22. SPRINGER, 2004.
Blackwell KL, Dressman H, Olson J, Rosen E, Marcom PK, Liotcheva V, et al. Molecular signatures that predict response to anthracycline-taxane based neoadjuvant chemotherapy. In: BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2004. p. S22–S22.
Blackwell, K. L., et al. “Molecular signatures that predict response to anthracycline-taxane based neoadjuvant chemotherapy.” BREAST CANCER RESEARCH AND TREATMENT, vol. 88, SPRINGER, 2004, pp. S22–S22.
Blackwell KL, Dressman H, Olson J, Rosen E, Marcom PK, Liotcheva V, Jones E, Vujaskovic Z, Huper G, Marks J, Dewhirst M, West M, Nevins J. Molecular signatures that predict response to anthracycline-taxane based neoadjuvant chemotherapy. BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2004. p. S22–S22.
Journal cover image

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

January 1, 2004

Volume

88

Start / End Page

S22 / S22

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

27th Annual Charles A Colman San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences